Jeremiah Frueauf
Sterne, Kessler, Goldstein & Fox (SKGF), USA
Biography
Frueauf, a director in the Biotechnology/Chemical Group, counsels domestic and international clients on the preparation, prosecution, and management of complex worldwide patent portfolios. He is also experienced in the research and preparation of freedom-to-operate, validity, infringement, and patentability analyses and uses these tools to advise his clients on their business strategy. Mr. Frueauf has experience in various inter partes matters, including district court litigation, U.S. Patent and Trademark Office litigation, and Section 337 investigations before the U.S. International Trade Commission. Mr. Frueauf is a contributing author of Patent Office Litigation, a two-volume set focused on the new contested proceedings under the America Invents Act published in 2012 by Thomson Reuters Westlaw. This book examines how the proceedings interact with other aspects of patent procurement and enforcement, and delivers practical analysis and advice.
Abstract
Abstract : Protecting your animal healthcare products: Patent eligibility challenges in the U.S. and Europe